Do oral bacteria alter the regenerative potential of stem cells? A concise review

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2067-2074

  Chatzivasileiou, Kyriaki ^a   Kriebel, Katja ^a   Steinhoff, Gustav ^a   Kreikemeyer, Bernd ^a   Lang, Hermann ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Bacteria; Inflammation; Periodontitis; Regeneration; Stem cells

Indexed keywords

ALKALINE PHOSPHATASE; BETA1 INTEGRIN; BONE SIALOPROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MICROSOMAL AMINOPEPTIDASE;

ARTICLE; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL VIABILITY; DENTAL FOLLICLE PROGENITOR CELL; DENTAL PULP STEM CELL; EMBRYONIC STEM CELL; GENE EXPRESSION; GINGIVA DERIVED MESENCHYMAL STEM CELL; GRAM NEGATIVE BACTERIUM; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MOUTH CAVITY; MOUTH FLORA; NONHUMAN; OSTEOBLAST; PERIODONTAL LIGAMENT STEM CELL; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; STEM CELL; BACTERIUM; CYTOLOGY; METABOLISM; MICROBIOLOGY; MOUTH; REGENERATION;

BACTERIA; CELL DIFFERENTIATION; HUMANS; IMMUNOMODULATION; MOUTH; REGENERATION; STEM CELLS;

EID: 84940787467     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12613     Document Type: Article

References (107)

1. Nemeth K, Mayer B, Mezey E. Modulation of bone marrow stromal cell functions in infectious diseases by toll-like receptor ligands. J Mol Med. 2010; 88: 5-10.
2. Kolb-Mäurer A, Goebel W. Susceptibility of hematopoietic stem cells to pathogens: role in virus/bacteria tropism and pathogenesis. FEMS Microbiol Lett. 2003; 226: 203-7.
3. Auletta JJ, Deans RJ, Bartholomew AM. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood. 2012; 119: 1801-9.
4. Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis. 2012; 18: 109-20.
5. Paster BJ, Olsen I, Aas JA, et al. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000. 2006; 42: 80-7.
6. Listgarten MA. Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study. J Periodontol. 1976; 47: 1-18.
7. Avila M, Ojcius DM, Yilmaz O. The oral microbiota: living with a permanent guest. DNA Cell Biol. 2009; 28: 405-11.
8. Jain S, Darveau RP. Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol 2000. 2010; 54: 53-70.
9. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000. 2005; 38: 135-87.
10. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010; 192: 5002-17.
11. Aas JA, Paster BJ, Stokes LN, et al. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43: 5721-32.
12. Zaura E, Keijser BJ, Huse SM, et al. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol. 2009; 9: 259.
13. Bik EM, Long CD, Armitage GC, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 2010; 4: 962-74.
14. Marsh PD, Percival RS. The oral microflora-friend or foe? Can we decide? Int Dent J. 2006; 56: 233-9.
15. Filoche S, Wong L, Sissons CH. Oral biofilms: emerging concepts in microbial ecology. J Dent Res. 2010; 89: 8-18.
16. Ruby EG. Symbiotic conversations are revealed under genetic interrogation. Nat Rev Microbiol. 2008; 6: 752-62.
17. Parahitiyawa NB, Scully C, Leung WK, et al. Exploring the oral bacterial flora: current status and future directions. Oral Dis. 2010; 16: 136-45.
18. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005; 366: 1809-20.
19. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol. 2008; 79: 1601-8.
20. Dewhirst FE, Tamer MA, Ericson RE, et al. The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol Immunol. 2000; 15: 196-202.
21. Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontol 2000. 1994; 5: 7-25.
22. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res. 1991; 26: 230-42.
23. Siqueira JF Jr, Rôças IN. Bacterial pathogenesis and mediators in apical periodontitis. Braz Dent J. 2007; 18: 267-80.
24. Noreen M, Shah MA, Mall SM, et al. TLR4 polymorphisms and disease susceptibility. Inflamm Res. 2012; 61: 177-88.
25. Lindhe J, Westfelt E, Nyman S, et al. Long-term effect of surgical/non-surgical treatment of periodontal disease. J Clin Periodontol. 1984; 11: 448-58.
26. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy (VIII). Probing attachment changes related to clinical characteristics. J Clin Periodontol. 1987; 14: 425-32.
27. Kaldahl WB, Kalkwarf KL, Patil KD, et al. Evaluation of four modalities of periodontal therapy. Mean probing depth, probing attachment level and recession changes. J Periodontol. 1988; 59: 783-93.
28. Caton JG. Overview of clinical trials on periodontal regeneration. Ann Periodontol. 1997; 2: 215-22.
29. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
30. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3: 393-403.
31. Friedenstein AJ, Chailakhyan RK, Latsinik NV, et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974; 17: 331-40.
32. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13: 4279-95.
33. Roubelakis MG, Bitsika V, Zagoura D, et al. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med. 2011; 15: 1896-913.
34. Fiegel HC, Lange C, Kneser U, et al. Fetal and adult liver stem cells for liver regeneration and tissue engineering. J Cell Mol Med. 2006; 10: 577-87.
35. Kögler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004; 200: 123-35.
36. Gronthos S, Mankani M, Brahim J, et al. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA. 2000; 97: 13625-30.
37. Morsczeck C, Götz W, Schierholz J, et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol. 2005; 24: 155-65.
38. Miura M, Gronthos S, Zhao M, et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA. 2003; 100: 5807-12.
39. Sonoyama W, Liu Y, Fang D, et al. Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS ONE. 2006; 1: e79.
40. Chen FM, Sun HH, Lu H, et al. Stem cell-delivery therapeutics for periodontal tissue regeneration. Biomaterials. 2012; 33: 6320-44.
41. Lindroos B, Mäenpää K, Ylikomi T, et al. Characterisation of human dental stem cells and buccal mucosa fibroblasts. Biochem Biophys Res Commun. 2008; 368: 329-35.
42. Huang GT, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res. 2009; 88: 792-806.
43. Kim BC, Bae H, Kwon IK, et al. Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their applications to tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2012; 18: 235-44.
44. Bartold PM, Shi S, Gronthos S. Stem cells and periodontal regeneration. Periodontol 2000. 2006; 40: 164-72.
45. Ivanovski S, Gronthos S, Shi S, et al. Stem cells in the periodontal ligament. Oral Dis. 2006; 12: 358-63.
46. Trofin EA, Monsarrat P, Kémoun P. Cell therapy of periodontium: from animal to human? Front Physiol. 2013; 4: 325.
47. Morsczeck CO, Drees J, Gosau M. Lipopolysaccharide from Escherichia coli but not from Porphyromonas gingivalis induce pro-inflammatory cytokines and alkaline phosphatase in dental follicle cells. Arch Oral Biol. 2012; 57: 1595-601.
48. Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther. 2010; 1: 30.
49. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007; 213: 341-7.
50. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol. 2002; 7: 62-71.
51. Kebschull M, Papapanou PN. Periodontal microbial complexes associated with specific cell and tissue responses. J Clin Periodontol. 2011; 38: 17-27.
52. Mo IF, Yip KH, Chan WK, et al. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol. 2008; 9: 52.
53. Kato H, Taguchi Y, Tominaga K, et al. Porphyromonas gingivalis LPS inhibits osteoblastic differentiation and promotes pro-inflammatory cytokine production in human periodontal ligament stem cells. Arch Oral Biol. 2014; 59: 167-75.
54. Stathopoulou PG, Galicia JC, Benakanakere MR, et al. Porphyromonas gingivalis induce apoptosis in human gingival epithelial cells through a gingipain-dependent mechanism. BMC Microbiol. 2009; 9: 107.
55. Laheij AM, de Soet JJ, Veerman EC, et al. The influence of oral bacteria on epithelial cell migration in vitro. Mediators Inflamm. 2013; 2013: 154532.
56. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000. 1994; 5: 78-111.
57. Bostanci N, Allaker RP, Belibasakis GN, et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine. 2007; 39: 147-56.
58. Yin L, Swanson B, An J, et al. Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2. J Oral Microbiol. 2010; 2: doi: 10.3402/jom.v2i0.5070.
59. Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev. 2010; 23: 37-46.
60. Guggenheim B, Gmür R, Galicia JC, et al. In vitro modeling of host-parasite interactions: the 'subgingival' biofilm challenge of primary human epithelial cells. BMC Microbiol. 2009; 9: 280.
61. Zijnge V, van Leeuwen MB, Degener JE, et al. Oral biofilm architecture on natural teeth. PLoS ONE. 2010; 5: e9321.
62. Sissons CH. Artificial dental plaque biofilm model systems. Adv Dent Res. 1997; 11: 110-26.
63. Park JH, Lee JK, Um HS, et al. A periodontitis-associated multispecies model of an oral biofilm. J Periodontal Implant Sci. 2014; 44: 79-84.
64. Tabenski L, Maisch T, Santarelli F, et al. Individual growth detection of bacterial species in an in vitro oral polymicrobial biofilm model. Arch Microbiol. 2014; 196: 819-28.
65. Li L, Michel R, Cohen J, et al. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiol. 2008; 8: 26.
66. Saito A, Inagaki S, Ishihara K. Differential ability of periodontopathic bacteria to modulate invasion of human gingival epithelial cells by Porphyromonas gingivalis. Microb Pathog. 2009; 47: 329-33.
67. Dabija-Wolter G, Sapkota D, Cimpan MR, et al. Limited in-depth invasion of Fusobacterium nucleatum into in vitro reconstructed human gingiva. Arch Oral Biol. 2012; 57: 344-51.
68. Maier E, Anderson RC, Roy NC. Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients. 2014; 7: 45-73.
69. Kriebel K, Biedermann A, Kreikemeyer B, et al. Anaerobic co-culture of mesenchymal stem cells and anaerobic pathogens - a new in vitro model system. PLoS ONE. 2013; 8: e78226.
70. Biedermann A, Kriebel K, Kreikemeyer B, et al. Interactions of anaerobic bacteria with dental stem cells: an in vitro study. PLoS ONE. 2014; 9: e110616.
71. Ulluwishewa D, Anderson RC, Young W, et al. Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier. Cell Microbiol. 2015; 17: 226-40.
72. Yamasaki M, Nakata K, Imaizumi I, et al. Cytotoxic effect of endodontic bacteria on periapical fibroblasts. J Endod. 1998; 24: 534-9.
73. Tabeta K, Yamazaki K, Akashi S, et al. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun. 2000; 68: 3731-5.
74. Wang PL, Oido-Mori M, Fujii T, et al. Heterogeneous expression of Toll-like receptor 4 and downregulation of Toll-like receptor 4 expression on human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide. Biochem Biophys Res Commun. 2001; 288: 863-7.
75. Pevsner-Fischer M, Morad V, Cohen-Sfady M, et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood. 2007; 109: 1422-32.
76. Jiang H, Patel PH, Kohlmaier A, et al. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell. 2009; 137: 1343-55.
77. Buchon N, Broderick NA, Poidevin M, et al. Drosophila intestinal response to bacterial infection: activation of host defense and stem cell proliferation. Cell Host Microbe. 2009; 5: 200-11.
78. Chatzivasileiou K, Lux CA, Steinhoff G, et al. Dental follicle progenitor cells responses to Porphyromonas gingivalis LPS. J Cell Mol Med. 2013; 17: 766-73.
79. van den Berk LC, Jansen BJH, Siebers-Vermeulen KG, et al. Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med. 2009; 13: 3415-26.
80. Liu Y, Gao Y, Zhan X, et al. TLR4 activation by lipopolysaccharide and Streptococcus mutans induces differential regulation of proliferation and migration in human dental pulp stem cells. J Endod. 2014; 40: 1375-81.
81. Yilmaz O. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology. 2008; 154: 2897-903.
82. Hynes K, Menicanin D, Gronthos S, et al. Clinical utility of stem cells for periodontal regeneration. Periodontol 2000. 2012; 59: 203-27.
83. Xiao L, Tsutsui T. Human dental mesenchymal stem cells and neural regeneration. Hum Cell. 2013; 26: 91-6.
84. Ronay V, Belibasakis GN, Attin T, et al. Expression of embryonic stem cell markers and osteogenic differentiation potential in cells derived from periodontal granulation tissue. Cell Biol Int. 2014; 38: 179-86.
85. Abe S, Imaizumi M, Mikami Y, et al. Oral bacterial extracts facilitate early osteogenic/dentinogenic differentiation in human dental pulp-derived cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109: 149-54.
86. Morozumi A. High concentration of sodium butyrate suppresses osteoblastic differentiation and mineralized nodule formation in ROS17/2.8 cells. J Oral Sci. 2011; 53: 509-16.
87. Nomiyama K, Kitamura C, Tsujisawa T, et al. Effects of lipopolysaccharide on newly established rat dental pulp-derived cell line with odontoblastic properties. J Endod. 2007; 33: 1187-91.
88. Yamagishi VT, Torneck CD, Friedman S, et al. Blockade of TLR2 inhibits Porphyromonas gingivalis suppression of mineralized matrix formation by human dental pulp stem cells. J Endod. 2011; 37: 812-8.
89. Hirose K, Isogai E, Mizugai H, et al. Inductive effect of Porphyromonas gingivalis fimbriae on differentiation of human monocytic tumor cell line U937. Oral Microbiol Immunol. 1996; 11: 62-4.
90. Zhang W, Swearingen EB, Ju J, et al. Porphyromonas gingivalis invades osteoblasts and inhibits bone formation. Microbes Infect. 2010; 12: 838-45.
91. Li Z, Jiang CM, An S, et al. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells. Oral Dis. 2014; 20: 25-34.
92. Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood. 2004; 103: 4619-21.
93. Sotiropoulou PA, Perez SA, Gritzapis AD, et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006; 24: 74-85.
94. Sato K, Ozaki K, Oh I, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007; 109: 228-34.
95. + regulatory T cells. Stem Cells. 2008; 26: 212-22.
96. + regulatory T cells. Clin Exp Immunol. 2009; 156: 149-60.
97. Ren G, Su J, Zhang L, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells. 2009; 27: 1954-62.
98. Zhang Q, Shi S, Liu Y, et al. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol. 2009; 183: 7787-98.
99. Reed DM, Foldes G, Gatheral T, et al. Pathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptors. PLoS ONE. 2014; 9: e91119.
100. Tomic S, Djokic J, Vasilijic S, et al. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells Dev. 2011; 20: 695-708.
101. Kol A, Foutouhi S, Walker NJ, et al. Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions. Stem Cells Dev. 2014; 23: 1831-43.
102. Chang J, Zhang C, Tani-Ishii N, et al. NF-kappaB activation in human dental pulp stem cells by TNF and LPS. J Dent Res. 2005; 84: 994-8.
103. He W, Qu T, Yu Q, et al. LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells. Int Endod J. 2013; 46: 128-36.
104. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010; 182: 1047-57.
105. Raffaghello L, Bianchi G, Bertolotto M, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells. 2008; 26: 151-62.
106. Feng Z, Weinberg A. Role of bacteria in health and disease of periodontal tissues. Periodontol 2000. 2006; 40: 50-76.
107. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110: 3499-506.